99 related articles for article (PubMed ID: 2427784)
1. [Prognostic value of various immunological indicators after radiation treatment of patients with cancer of the lungs and esophagus].
Ogorodnikova SG; Sherban' EI; Gerasimiak VG
Lab Delo; 1986; (6):355-7. PubMed ID: 2427784
[No Abstract] [Full Text] [Related]
2. [Radiation myelitis during gamma-therapy of cancer of the esophagus and lungs].
Khaĭrushev ZhA; Perzadaev AN; Balmukhanov SB; Abdrakhmanov ZhN
Med Radiol (Mosk); 1972 Feb; 17(2):33-41. PubMed ID: 5036246
[No Abstract] [Full Text] [Related]
3. [Influence of the localization on the prognostic value of E, E-active and autologous rosettes in lung, esophagus and otorhinolaryngologic cancer].
Youinou P; Miossec P; Labat JP; Clavier J; Coatalem M; Guillerm D; Kerbrat G
Sem Hop; 1983 Dec; 59(44):3033-7. PubMed ID: 6320389
[TBL] [Abstract][Full Text] [Related]
4. [Delayed hypersensitivity response of the skin to 2,4-dinitrochlorobenzene and old tuberculin in patients with lung cancer].
Fan XJ
Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):333-6. PubMed ID: 6653356
[No Abstract] [Full Text] [Related]
5. [Various cellular immunity indices in patients with esophageal cancer].
Tsoĭ AI; Chichua NA; Kolycheva NI
Vopr Onkol; 1979; 25(12):15-8. PubMed ID: 516576
[TBL] [Abstract][Full Text] [Related]
6. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
[No Abstract] [Full Text] [Related]
7. [Methyl heptine carbonate skin test in lung cancer--correlation with stage and prognosis].
Takanami I; Nakayama H; Ishihara T; Yanai N
Gan No Rinsho; 1984 Apr; 30(4):340-3. PubMed ID: 6727035
[TBL] [Abstract][Full Text] [Related]
8. [Delayed-type hypersensitivity skin test with modified autologous lymphocytes in the diagnosis and monitoring of patients with lung cancer].
Bakhlaev IE; Erkhov VS; Ageenko AI; Oleĭnik EK; Trakhtenberg AK
Vopr Onkol; 1994; 40(7-12):284-8. PubMed ID: 7610621
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous delayed hypersensitivity to costus root oil in lung cancer].
Takanami I; Ishihara T; Yanai N
Gan No Rinsho; 1985 Sep; 31(11):1362-6. PubMed ID: 4068238
[TBL] [Abstract][Full Text] [Related]
10. [Study of delayed skin hypersensitivity using the multitest in an intensive care unit].
Kienlen J; Chardon P; Nury G; Lubrano JF; Messmer JC; du Cailar J
Ann Anesthesiol Fr; 1981; 22(3):285-91. PubMed ID: 6117235
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of tumor-associated delayed cutaneous hypersensitivity reactions in patients with lung cancer and in pateients with carcinoma of the cervix.
Wells SA; Burdick JF; Christiansen C; Ketcham AS; Adkins PC
Natl Cancer Inst Monogr; 1973 Jun; 37():197-203. PubMed ID: 4713780
[No Abstract] [Full Text] [Related]
12. [Clinical application of multiple fractions per day in lung and esophageal cancer].
Kikuchi Y
Gan No Rinsho; 1988 Oct; 34(13):1773-82. PubMed ID: 2848956
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant levamisole in the treatment of patients with resectable lung cancer.
Amery WK
Ann Clin Res; 1980; 12 Suppl 27():1-83. PubMed ID: 6999969
[No Abstract] [Full Text] [Related]
14. Effect of radiation therapy on mumps-delayed type hypersensitivity reaction in lymphoma and carcinoma patients.
Check JH; Damsker JI; Brady LW; O'Neill EA
Cancer; 1973 Sep; 32(3):580-4. PubMed ID: 4726964
[No Abstract] [Full Text] [Related]
15. [Humoral and cellular immunity in patients with cancer of the esophagus. Effects of nutritional preparation].
Martin C; Auffray JP; Barthelemy A; Fulachier V; Fuentes P; Gouin F
Ann Anesthesiol Fr; 1981; 22(3):259-64. PubMed ID: 6117231
[No Abstract] [Full Text] [Related]
16. [Role of the indicators of nonspecific immunity in diagnosis of skin neoplasms and skin manifestations in patients with cancer of the visceral organs].
Karpushkin VP; Kochetkova VA
Vestn Dermatol Venerol; 1974 Jan; (1):42-6. PubMed ID: 4466155
[No Abstract] [Full Text] [Related]
17. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
Liu X; An H; Jiang Y
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
[TBL] [Abstract][Full Text] [Related]
18. [The Su-polysaccharide skin test in lung cancer].
Harada J; Horiguchi T; Oki K; Miyamoto H; Osada T
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2697-702. PubMed ID: 3307634
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of hormonal and immunological indices in the combined treatment of esophageal cancer].
Bordiushkov IuN; Rubtsov VR; Maliutina LI; Vagner VP; Cherniavskaia GIa
Vopr Onkol; 1982; 28(7):13-22. PubMed ID: 7101822
[TBL] [Abstract][Full Text] [Related]
20. Delayed hypersensitivity in cancer patients: cutaneous and in vitro lymphocyte response to specific antigens.
Nelson HS
J Natl Cancer Inst; 1969 May; 42(5):765-70. PubMed ID: 5797546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
